Concepedia

Publication | Open Access

A randomized controlled trial of lamivudine to treat acute hepatitis B

202

Citations

11

References

2006

Year

Abstract

Though lamivudine causes a greater decrease in levels of HBV DNA, it does not cause significantly greater biochemical and clinical improvement as compared to placebo in patients with acute hepatitis B.

References

YearCitations

Page 1